8-Cyclopentyl-1,3-dimethylxanthine

From WikiMD's WELLNESSPEDIA

8-Cyclopentyl-1,3-dimethylxanthine.svg

Chemical compound

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

8-Cyclopentyl-1,3-dimethylxanthine is a chemical compound that belongs to the class of xanthine derivatives. It is known for its role as a potent and selective adenosine receptor antagonist, particularly targeting the A1 receptor subtype.

Chemical Structure and Properties[edit]

8-Cyclopentyl-1,3-dimethylxanthine has a molecular structure that includes a xanthine core with a cyclopentyl group at the 8-position and two methyl groups at the 1- and 3-positions. The chemical formula is C13H18N4O2.

Mechanism of Action[edit]

As an adenosine receptor antagonist, 8-Cyclopentyl-1,3-dimethylxanthine inhibits the action of adenosine at the A1 receptor. This inhibition can lead to various physiological effects, including increased neurotransmitter release and enhanced neuronal activity.

Pharmacological Effects[edit]

The compound is primarily used in research to study the role of adenosine in the central nervous system and its effects on neurotransmission. It has been shown to have potential applications in the treatment of neurological disorders and cardiovascular diseases.

Research Applications[edit]

8-Cyclopentyl-1,3-dimethylxanthine is widely used in pharmacological studies to investigate the function of adenosine receptors. It serves as a tool to understand the physiological and pathological roles of adenosine in various tissues.

Safety and Toxicity[edit]

The safety profile of 8-Cyclopentyl-1,3-dimethylxanthine is not well-documented, and it should be handled with care in a laboratory setting. Proper safety protocols should be followed to avoid any potential hazards.

See Also[edit]

References[edit]


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=8-Cyclopentyl-1,3-dimethylxanthine&oldid=5807444"